Elevated levels of HSL and ATGL are indicative of promoted lipolysis and reduced lipogenesis induced by erythropoietin and darbepoetin alpha for alleviation of NAFLD (Tsuma et al. 2019). The gene discussed is PNPLA2; the disease is metabolic dysfunction-associated steatotic liver disease.